MKI67 and neoplasm: Neither the number of somatic mutations nor the number of oncogenic mutations was associated with the following clinicopathological characteristics: sex, age, tumor site, molecular subtype, Ki-67 proliferation index, B symptoms, ECOG score, IPI score, and clinical stage.